Jonathan S.E. Hellewell

1.3k total citations
58 papers, 1.0k citations indexed

About

Jonathan S.E. Hellewell is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Clinical Psychology. According to data from OpenAlex, Jonathan S.E. Hellewell has authored 58 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Psychiatry and Mental health, 12 papers in Cognitive Neuroscience and 9 papers in Clinical Psychology. Recurrent topics in Jonathan S.E. Hellewell's work include Schizophrenia research and treatment (30 papers), Mental Health and Psychiatry (9 papers) and Bipolar Disorder and Treatment (7 papers). Jonathan S.E. Hellewell is often cited by papers focused on Schizophrenia research and treatment (30 papers), Mental Health and Psychiatry (9 papers) and Bipolar Disorder and Treatment (7 papers). Jonathan S.E. Hellewell collaborates with scholars based in United Kingdom, Denmark and Austria. Jonathan S.E. Hellewell's co-authors include J.F.W. Deakin, John Stirling, Andrew Blakey, Chris Frith, Karl Friston, Robin Murray, Francisco Silveira Guimarães, Paul M. Grasby, Steven R. Hirsch and Peter F. Liddle and has published in prestigious journals such as NeuroImage, The British Journal of Psychiatry and Psychological Medicine.

In The Last Decade

Jonathan S.E. Hellewell

57 papers receiving 955 citations

Peers

Jonathan S.E. Hellewell
Mário R. Louzã Brazil
Virginia N. Iannone United States
Philip D. Harvey United States
Richard Cosway United Kingdom
Daniel Bergé Spain
Philip D. Harvey United States
Marta Rapado‐Castro Spain
Fiona Gallacher United States
D.H. Linszen Netherlands
Marjorie McMeniman United States
Mário R. Louzã Brazil
Jonathan S.E. Hellewell
Citations per year, relative to Jonathan S.E. Hellewell Jonathan S.E. Hellewell (= 1×) peers Mário R. Louzã

Countries citing papers authored by Jonathan S.E. Hellewell

Since Specialization
Citations

This map shows the geographic impact of Jonathan S.E. Hellewell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan S.E. Hellewell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan S.E. Hellewell more than expected).

Fields of papers citing papers by Jonathan S.E. Hellewell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan S.E. Hellewell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan S.E. Hellewell. The network helps show where Jonathan S.E. Hellewell may publish in the future.

Co-authorship network of co-authors of Jonathan S.E. Hellewell

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan S.E. Hellewell. A scholar is included among the top collaborators of Jonathan S.E. Hellewell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan S.E. Hellewell. Jonathan S.E. Hellewell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hellewell, Jonathan S.E., et al.. (2007). A review of the efficacy and tolerability of agomelatine in the treatment of major depression. Expert Opinion on Investigational Drugs. 16(12). 1999–2004. 18 indexed citations
2.
3.
4.
Stirling, John, Jonathan S.E. Hellewell, Andrew Blakey, & J.F.W. Deakin. (2006). Thought disorder in schizophrenia is associated with both executive dysfunction and circumscribed impairments in semantic function. Psychological Medicine. 36(4). 475–484. 72 indexed citations
5.
Os, Jim van, A. Carlo Altamura, Julio Bobes, et al.. (2003). Evaluation of the Two-Way Communication Checklist as a clinical intervention. The British Journal of Psychiatry. 184(1). 79–83. 52 indexed citations
6.
Hellewell, Jonathan S.E.. (2002). Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: a review of efficacy and tolerability. Journal of Affective Disorders. 72. S23–S34. 33 indexed citations
7.
Hellewell, Jonathan S.E.. (2002). Patients?? Subjective Experiences of Antipsychotics. CNS Drugs. 16(7). 457–471. 59 indexed citations
8.
Chaudhry, Imran B., et al.. (2002). Effects of the 5HT antagonist cyproheptadine on neuropsychological function in chronic schizophrenia. Schizophrenia Research. 53(1-2). 17–24. 21 indexed citations
9.
Os, Jim van, Julio Bobes, David Owens, et al.. (2002). 2‐COM: an instrument to facilitate patient–professional communication in routine clinical practice. Acta Psychiatrica Scandinavica. 106(6). 446–452. 19 indexed citations
10.
Weiden, Peter J., Penelope Hopwood, A. George Awad, et al.. (2001). An Innovative Approach to Clinical Communication in Schizophrenia: The Approaches to Schizophrenia Communication Checklists. CNS Spectrums. 6(4). 333–338. 30 indexed citations
11.
Stirling, John, et al.. (2001). Self-Monitoring Dysfunction and the Positive Symptoms of Schizophrenia. Psychopathology. 34(4). 198–202. 37 indexed citations
12.
Hellewell, Jonathan S.E. & Jes Gerlach. (2000). Opportunities and challenges presented by the new generation antipsychotics. International Journal of Psychiatry in Clinical Practice. 4(1). 53–61. 7 indexed citations
13.
Altamura, A. Carlo, Julio Bobes, David Owens, et al.. (2000). Principles of Practice from the European Expert Panel on the Contemporary Treatment of Schizophrenia. International Journal of Psychiatry in Clinical Practice. 4(1). 1–11. 12 indexed citations
14.
Hellewell, Jonathan S.E., et al.. (1999). Patient satisfaction and acceptability of long-term treatment with quetiapine. International Journal of Psychiatry in Clinical Practice. 3(2). 105–113. 36 indexed citations
15.
Hellewell, Jonathan S.E., et al.. (1998). Self-monitoring dysfunction and the schizophrenic symptoms of alien control. Psychological Medicine. 28(3). 675–683. 65 indexed citations
16.
Hellewell, Jonathan S.E. & Marc Cantillon. (1998). Antipsychotic tolerability: The attitudes and perceptions of medical professionals, patients and caregivers towards the side effects of antipsychotic therapy. European Neuropsychopharmacology. 8. S248–S248. 12 indexed citations
17.
Stirling, John, Jonathan S.E. Hellewell, & Jacqueline Hewitt. (1997). Verbal memory impairment in schizophrenia: no sparing of short-term recall. Schizophrenia Research. 25(2). 85–95. 38 indexed citations
18.
Hellewell, Jonathan S.E., et al.. (1996). A review of the efficacy of “Seroquel” (quetiapine) in the treatment of the positive and negative symptoms of schizophrenia. European Neuropsychopharmacology. 6. S4–14. 1 indexed citations
19.
Hellewell, Jonathan S.E., John Connell, & J.F.W. Deakin. (1994). Affect Judgement and Facial Recognition Memory in Schizophrenia. Psychopathology. 27(3-5). 255–261. 29 indexed citations
20.
Hellewell, Jonathan S.E. & Elizabeth Pugh. (1992). Reply. Psychiatric Bulletin. 16(9). 573–573. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mário R. Louzã Breakdown of academic impact, for papers by Virginia N. Iannone Breakdown of academic impact, for papers by Philip D. Harvey Breakdown of academic impact, for papers by Richard Cosway Breakdown of academic impact, for papers by Daniel Bergé Breakdown of academic impact, for papers by Philip D. Harvey Breakdown of academic impact, for papers by Marta Rapado‐Castro Breakdown of academic impact, for papers by Fiona Gallacher Breakdown of academic impact, for papers by D.H. Linszen Breakdown of academic impact, for papers by Marjorie McMeniman
Rankless by CCL
2026